Drugs affecting blood coagulation, platelet aggregation and thrombosis Flashcards

1
Q

What factor number is prothrombin?

And thrombin?

A

Prothrombin - Factor II

Thrombin - Factor IIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which factor stabilises fibrin?

A

Factor XIIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which endogenous chemicals suppress platelet activation?

A

Thromboxane A2
Adrenaline
ATP
5-HT (serotonin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define thrombosis

A

Formation of a clot (thrombus) inside an entact blood vessel (therefore no need for it)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is an egotheromatous plaque?

A

Plaques caused by endothelial damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name three general mechanisms of how to prevent clots

A

Target coagulation
Target platelet activation
Promote fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Targeting coagulation is more effective in which type of thrombosis?
Classes of drugs to help?

A

Venous thrombosis
Parenteral anticoagulants
Oral anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name some parenteral anticoagulant drug classes

A

Heparin

Hirudins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Classes of oral anticoagulant drugs

A

Warfarin
Thrombin inhibitors
Factor Xa inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Heparins are what kind of biomolecule?
Where do they occur naturally, if at all?
How do they act?
2 size ranges

A

Micropolysaccharides
Occur naturally, made by endothelium, mast cells and basophils
Inhibits thrombin, factor Xa and factor IXa
2 types:
-Unfractioned - >/= 18 sugar units (preferred for patients with renal failure)
-Low molecular weight heparins >/=5 sugar units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fondaparinux

A

Same mechanism as thrombin
Acts via antithombin III (endogenous inhibitor of coagulation), forms inactive complex with thrombin, factor IXa, factor Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does Heparin work

A

-Acts on all of cascade - intrinsic, extrinisic and common pathways
-Inhibits factors XII, XI, IX, VIII, Thrombin (IIa)
-increases rate of formation of antithrombin III complexes 1000 fold
-to block thrombin, heparin must bind both ATIII and thrombin
-Heparin increases the formation of the factor Xa/ATIII complex WITHOUT binding factor Xa
-Blocks factor IXa from activating factor X, hence prevents factor II (prothrombin) from becoming thrombin (factor IIa)
Therefore prevents platelet activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LMW heparins affect what

A

LMW heparins are shorter and affect factor Xa but not thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Heparin problems

A

Risk of haemorrhage:

  • mild - cease administration
  • severe - inactivate heparin using protamine (forms inactive complex but is only partially effective against LMW heparin)
  • HIT (heparin-induced thrombocytopaenia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is heparin-induced thrombocytopaenia?

A

Type I - direct effect of heparin (causes clumpng)

Type II - heparin induces formation of antibodies that bind to platelets - serious! Discontinue use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What heparin doesn’t cause HIT?

A

The heparinoid drug Denapanoid
Related to LMW Heparin
Safe alternative

17
Q

How how hirudins work?

A

block/inhibit factor IIa (thrombin)

18
Q

Bivalirudin use

A

Hirudin analogue used in unstable angina and some MI patients

19
Q

Carboxylation of which clotting factors is essential to their function?
What kind of modification is this?
What does this process require?

A

II, VII, IX and X
Post-translational modification

Process requires enzymes that need vitamin K to function. Vitamin K is oxidised in the reaction.
For continued function, the oxidised vitamin K must be reduced by Vitamin-K reductase

20
Q

How does warfarin work?

A

Completely inhibits the enzyme vitamin K reductase
Therefore reduces clotting factor maturation (II, VII, IX, X)
Anticoagulant effect

21
Q

Why doees warfarin have a slow onset?

A

Need for pre-existing clotting factors to become depleted

22
Q

In what circumstances do you give warfarin and for how long?

A

1st DVT/pulmonary embolism - give for 3 months

2nd - give lifelong

23
Q

Warfarin overdose treatment

A

Vitamin K

24
Q

effect of warfarin on microorganisms in gut

A

MOs make vitamin K - antibiotics may affect warfarin efficacy

25
Q

Side effects of warfarin and interactions

A

Haemorrhage common (nase, pharynx, GI tract, urinary tract)

  • mild - stop administation
  • severe - give vitamin K, purified clotting factors and whole blood

Skin necrosis
Avoid in pregnancy as a tetrogen, crosses placenta and can cause haemorrhage in neonates
Notorious for drug interactions, induction/inhibition by other drugs as CYP450
Need for regular monitoring - INR, blood coagulation test

26
Q

How thrombin inhibitors work
When are they given?
Common side effect?

A
oral anticoagulants 
Not widely used 
-Block action of thrombin 
-or block action of factor Xa
Given after joint replacement,
Haemorrhage common unwanted effect
27
Q

Which drug blocks action of Thrombin

A

dabigatran

28
Q

Which 2 drugs block action of factor Xa

A

Apixaban

Rivaroxaban

29
Q

PGI2 effect on platelet aggregation

And what about Thromboxane A2?

A

PGI2 reduces platelet aggregation by ↑cAMP
Thromboxane A2 ↑platelet aggregation by ↓cAMP
Note:
Atheromaous plaques release PGI2

30
Q

Aspirin as an anticoagulant
How does it work?
Low dose effects
High dose effects

A

Blocks COX enzyme
Platelets cannot make new COX as they have no nuclei
TXA2 production and platelet aggregation blocked until new platelets are produced
Endothelial cells can produce more COX so PGI2 production is spared
Low dose - affect platelets
High dose - reduced PGI2 production by endothelium, therefore more risk of platelet aggregation

31
Q

Epoprostenol
What does it do?
How and when is it given?

A

Prostacyclin (PGI2) agonist antiplatelet therapy
Mimics effects of prostacyclin therefore reduces platelet aggregaton by ↑cAMP
Given by IV infusion (unstable) during haemodialysis and for pulmonary hypertension
Powerful vasodilator therefore has adverse effects

32
Q

Dipyramidamole action

A

Blocks PDE so reduced cAMP breakdown so ↑cAMP

but also inhibits TxA2 synthesis and ADP production